Collaboration Between Laboratory, Nursing, and Pharmacy Teams in the Early Detection and Management of Drug-Induced Organ Toxicity
DOI:
https://doi.org/10.22399/ijcesen.5012Keywords:
Drug-induced organ toxicity, interprofessional collaboration, laboratory medicine, nursing, pharmacy, hepatotoxicityAbstract
Collaboration between laboratory, nursing, and pharmacy teams plays a pivotal role in the early detection and management of drug-induced organ toxicity, a critical aspect of patient safety and effective healthcare. Laboratories are responsible for conducting various tests to identify biomarkers and physiological changes indicative of organ toxicity, providing essential data that can inform clinical decisions. When nurses are integral to this process, they actively monitor patients for signs of adverse drug reactions and report any changes in their condition. This real-time communication ensures that laboratory findings are swiftly translated into actionable insights, bridging the gap between diagnostic results and patient care. Pharmacy teams further enhance this collaborative approach by offering expertise in pharmacotherapy and medication management. They evaluate patient medication regimens to identify potential drug interactions and contraindications while recommending alternatives when necessary. Through interdisciplinary rounds and discussions, pharmacists, nurses, and laboratory professionals can establish protocols for monitoring patients at risk for organ toxicity, developing a coordinated strategy for both prevention and intervention. By fostering a team-oriented environment, healthcare providers can enhance early detection efforts, optimize treatment strategies, and ultimately improve patient outcomes in the management of drug-induced organ toxicity.
References
[1] Omboni S., Caserini M. Effectiveness of pharmacist’s intervention in the management of cardiovascular diseases. Open Heart. 2018;5(1)
[2] Jones C.D., Jones J., Richard A., Bowles K., Lahoff D., Boxer R.S., Masoudi F.A., Coleman E.A., Wald H.L. "Connecting the dots": a qualitative study of home health nurse perspectives on coordinating care for recently discharged patients. J. Gen. Intern. Med. 2017;32(10):1114–1121.
[3] McLean D.L., McAlister F.A., Johnson J.A. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN) Arch. Intern. Med. 2008;168:2355–2361.
[4] Peters M., Godfrey C., Khalil H., Mcinerney P., Parker D., Soares C. Guidance for conducting systematic scoping reviews. Int. J. Evid. Based Healthc. 2015;13.
[5] Hadi M.A., Alldred D.P., Briggs M., Closs S.J. A combined nurse-pharmacist managed pain clinic: joint venture of public and private sectors. Int. J. Clin. Pharm. 2012;34(1):1–3.
[6] Flynn A., Anderson C. Meaningful collaboration. Nurs. Manag. 2012;43(12):2–5.
[7] Ploeg J., Canesi M., D Fraser K., McAiney C., Kaasalainen S., Markle-Reid M., Dufour S., Garland Baird L., Chambers T. Experiences of community-dwelling older adults living with multiple chronic conditions: a qualitative study. BMJ Open. 2019;9(3).
[8] Dennis S., May J., Perkins D., Zwar N., Sibbald B., Hasan I. What evidence is there to support skill mix changes between GPs, pharmacists and practice nurses in the care of elderly people living in the community? Australia & New Zealand Health Policy. 2009;6(7).
[9] D’Amour D., Ferrada-Videla M., San Martin Rodriguez L., Beaulieu M.-.D. The Conceptual basis for interprofessional collaboration: core concepts and theoretical frameworks. J. Interprof. Care. 2005;19(S1):116–131.
[10] Lee C.Y., Goeman D., Beanland C., Elliott R.A. Challenges and barriers associated with medication management for home nursing clients in Australia: a qualitative study combining the perspectives of community nurses. Community Pharmacists and GPs. Family Practice. 2018;36(3):332–342.
[11] Canadian Patient Safety Institute [CPSI]. (2017). Safety Improvement Projects.
[12] Engel J., Prentice D. The ethics of interprofessional collaboration. Nurs. Ethics. 2013;20(4):426–435.
[13] Celio J., Ninane F., Bugnon O., Schneider M.P. Pharmacist-nurse collaborations in medication adherence-enhancing interventions: a review. Patient Educ. Couns. 2018;101(7):1175–1192.
[14] Bell H.T., Granas A.G., Enmarker I., Omli R., Steinsbekk A. Nurses’ and pharmacists’ learning experiences from participating in interprofessional medication reviews for elderly in primary health care—A qualitative study. BMC Fam. Pract. 2017;18:1–9.
[15] Porter A.C., Fitzgibbon M.L., Fischer M.J., Gallardo R., Berbaum M.L., Lash J.P., Castillo S., Schiffer L., Sharp L.K., Tulley J., Arruda J.A., Hynes D.M. Rationale and design of a patient-centered medical home intervention for patients with end-stage renal disease on hemodialysis. Contemp. Clin. Trials. 2015;42:1–8.
[16] Alper, E., O'Malley, T.A., Greenwald, J. (2020). Hospital discharge and readmission.
[17] LeBlanc R.G., Choi J. Optimizing medication safety in the home. Home Healthc. Now. 2015;33(6):313–319.
[18] Pherson E., Roth J., Nkimbeng M., Boyd C., Szanton S.L. Ensuring safe and optimal medication use in older community residents: collaboration between a nurse and a pharmacist. Geriatr. Nurs. (Minneap) 2018;39(5):554–559.
[19] Bayraktar-Ekincioglu A., Kucuk E. The differences in the assessments of side effects at an oncology outpatient clinic. Int. J. Clin. Pharm. 2018;40(2):386–393.
[20] O'Daniel., M. & Rosenstein, A.H. (2008). Professional communication and team collaboration. In R.G. Hughes (Ed.), Patient Safety and Quality: An Evidence-Based Handbook for Nurses (Chapter 33). Rockville, MD: Agency for Healthcare Research and Quality (US).
[21] Lee C.Y., Beanland C., Goeman D., Petrie N., Petrie B., Vise F., Gray J., Elliott R.A. Improving medication safety for home nursing clients: a prospective observational study of a novel clinical pharmacy service— the visiting pharmacist (ViP) study. J. Clin. Pharmacy & Therapeutics. 2018;43(6):813–821.
[22] Perraudin C., Bourdin A., Spertini F., Berger J., Bugnon O. Switching patients to home-based subcutaneous immunoglobulin: an economic evaluation of an interprofessional drug therapy management program. J. Clin. Immunol. 2016;36(5):502–510.
[23] Lyson, H.C., Sharma, A.E., Cherian, R., Patterson, E.S., McDonald, K.M., Lee, S.-.Y., & Sarkar, U. (2019). A qualitative analysis of outpatient medication use in community settings. J. Patient Safety: Publish Ahead of Print.
[24] Hunt R. Introduction to Community-based Nursing. 5th Ed. Lippincott Williams & Wilkins; 2012.
[25] Banning M. Medication management: older people and nursing. Nurs. Older People. 2005;17(7):20–23.
[26] Hadi M.A., Alldred D.P., Briggs M., Marczewski K., Closs S.J. Effectiveness of a community based nurse-pharmacist managed pain clinic: a mixed-methods study. Int. J. Nurs. Stud. 2016;53:219–227.
[27] Meyer-Massetti C., Hofstetter V., Hedinger-Grogg B., Meier C.R., Guglielmo B.J. Medication-related problems during transfer from hospital to home care: baseline data from Switzerland. Int. J. Clin. Pharm. 2018;40(6):1614–1620.
[28] Hohl C.M., Woo S.A., Cragg A., Wickham M.E., Ackerley C., Scheuermeyer F., Villanyi D. Repeat adverse drug events associated with outpatient medications: a descriptive analysis of 3 observational studies in British Columbia. Canada. CMAJ Open. 2019;7(3):E446–E453.
[29] Saint-Pierre C., Herskovic V., Sepúlveda M. Multidisciplinary collaboration in primary care: a systematic review. Fam. Pract. 2018;35(2):132–141.
[30] Institute for Safe Medication Practices Canada [ISMP Canada]. (2007). Definitions.
[31] Levac D., Colquhoun H., O’Brien K.K. Scoping studies: advancing the methodology. Implementation Sci. 2010;69(5).
[32] Arksey H., O’Malley L. Scoping studies: towards a methodological framework. Int. J. Soc. Res. Methodol. 2005;8(1):19–32.
[33] Ellenbecker C.H., Samia L., Cushman M.J., Alster K. Patient Safety and Quality in Home Health Care. 2009;1:40.
[34] Elliott R.A., Lee C.Y., Beanland C., Goeman D.P., Petrie N., Petrie B., Vise F., Gray J. Development of a clinical pharmacy model within an australian home nursing service using co-creation and participatory action research: the visiting pharmacist (ViP) study. BMJ Open. 2017;7(11).
[35] Hamano J., Ozone S., Tokuda Y. A comparison of estimated drug costs of potentially inappropriate medications between older patients receiving nurse home visit services and patients receiving pharmacist home visit services: a cross-sectional and propensity score analysis. BMC Health Serv. Res. 2015;15.
[36] Braungart C., Watson A., Rubin R. The effects of interprofessional collaboration on nurse managed warfarin program. J. Interprofessional Education & Practice. 2018;13:56–58.
[37] Godfrey, C.M., Harrison, M.B., Lang, A., Macdonald, M., Leung, T., & Swab, M. (2013). Homecare safety and medication management with older adults: a scoping review of the quantitative and qualitative evidence.
[38] Chapman E., Haby M.M., Toma T.S., de Bortoli M.C., Illanes E., Oliveros M.J., Barreto J.O. Knowledge translation strategies for dissemination with a focus on healthcare recipients: an overview of systematic reviews. Implementation Sci. 2020;15(1).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal of Computational and Experimental Science and Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
